Source Post
Down 43% in 2025, Should Investors Buy Novo Nordisk Stock? | #nvo #novonordisk #stocks #trading
Nov 20, 2025
The creator maintains a buy rating on Novo Nordisk despite a 43% year-to-date decline, viewing the current struggles as a potential long-term opportunity.
Linked Mentions
Tickers discussed in this post
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.